Suppr超能文献

在庞贝氏症小鼠中通过肌肉注射腺相关病毒(AAV)后运动神经元组织病理学的持续改善。

Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice.

作者信息

Elmallah Mai K, Falk Darin J, Nayak Sushrusha, Federico Roland A, Sandhu Milapjit S, Poirier Amy, Byrne Barry J, Fuller David D

机构信息

Department of Pediatrics, Division of Pulmonary Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.

1] Department of Pediatrics, Divisions of Cellular and Molecular Therapy and Pediatric Cardiology, College of Medicine, University of Florida, Gainesville, Florida, USA [2] Powell Gene Therapy Center, University of Florida, Gainesville, Florida, USA.

出版信息

Mol Ther. 2014 Apr;22(4):702-12. doi: 10.1038/mt.2013.282. Epub 2013 Dec 12.

Abstract

Pompe disease is an autosomal recessive disorder caused by mutations in the acid-α glucosidase (GAA) gene. Lingual dysfunction is prominent but does not respond to conventional enzyme replacement therapy (ERT). Using Pompe (Gaa(-/-)) mice, we tested the hypothesis that intralingual delivery of viral vectors encoding GAA results in GAA expression and glycogen clearance in both tongue myofibers and hypoglossal (XII) motoneurons. An intralingual injection of an adeno-associated virus (AAV) vector encoding GAA (serotypes 1 or 9; 1 × 10(11) vector genomes, CMV promoter) was performed in 2-month-old Gaa(-/-) mice, and tissues were harvested 4 months later. Both serotypes robustly transduced tongue myofibers with histological confirmation of GAA expression (immunochemistry) and glycogen clearance (Period acid-Schiff stain). Both vectors also led to medullary transgene expression. GAA-positive motoneurons did not show the histopathologic features which are typical in Pompe disease and animal models. Intralingual injection with the AAV9 vector resulted in approximately threefold more GAA-positive XII motoneurons (P < 0.02 versus AAV1); the AAV9 group also gained more body weight over the course of the study (P < 0.05 versus AAV1 and sham). We conclude that intralingual injection of AAV1 or AAV9 drives persistent GAA expression in tongue myofibers and motoneurons, but AAV9 may more effectively target motoneurons.

摘要

庞贝病是一种常染色体隐性疾病,由酸性α-葡萄糖苷酶(GAA)基因突变引起。舌功能障碍较为突出,但对传统的酶替代疗法(ERT)无反应。我们利用庞贝病(Gaa(-/-))小鼠,检验了以下假说:向舌内递送编码GAA的病毒载体可导致舌肌纤维和舌下(XII)运动神经元中GAA表达及糖原清除。对2月龄的Gaa(-/-)小鼠进行舌内注射编码GAA的腺相关病毒(AAV)载体(血清型1或9;1×10(11)载体基因组,CMV启动子),4个月后采集组织。两种血清型均能有效地转导舌肌纤维,通过免疫化学证实GAA表达,过碘酸希夫染色证实糖原清除。两种载体还导致延髓转基因表达。GAA阳性运动神经元未表现出庞贝病及动物模型中典型的组织病理学特征。舌内注射AAV9载体导致GAA阳性XII运动神经元数量增加约三倍(与AAV1相比,P < 0.02);在研究过程中,AAV9组体重增加也更多(与AAV1和假注射组相比,P < 0.05)。我们得出结论,舌内注射AAV1或AAV9可驱动舌肌纤维和运动神经元中持续的GAA表达,但AAV9可能更有效地靶向运动神经元。

相似文献

1
Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice.
Mol Ther. 2014 Apr;22(4):702-12. doi: 10.1038/mt.2013.282. Epub 2013 Dec 12.
2
Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease.
Hum Gene Ther. 2019 Jan;30(1):57-68. doi: 10.1089/hum.2018.016. Epub 2018 Jul 25.
3
Chemogenetic activation of hypoglossal motoneurons in a mouse model of Pompe disease.
J Neurophysiol. 2022 Nov 1;128(5):1133-1142. doi: 10.1152/jn.00026.2022. Epub 2022 Aug 17.
5
AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice.
Mol Ther Methods Clin Dev. 2019 Aug 31;15:194-203. doi: 10.1016/j.omtm.2019.08.009. eCollection 2019 Dec 13.
7
Muscle-specific, liver-detargeted adeno-associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa mice.
J Inherit Metab Dis. 2024 Jan;47(1):119-134. doi: 10.1002/jimd.12625. Epub 2023 May 29.
8
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase.
Mol Ther. 2020 Sep 2;28(9):2056-2072. doi: 10.1016/j.ymthe.2020.05.025. Epub 2020 May 30.
9
10
Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.
Hum Gene Ther. 2015 Nov;26(11):743-50. doi: 10.1089/hum.2015.033. Epub 2015 Sep 29.

引用本文的文献

1
GAA replacement improves respiratory muscle, neural, and alveolar pathology in the pompe mouse.
Respir Physiol Neurobiol. 2025 Jul;335:104433. doi: 10.1016/j.resp.2025.104433. Epub 2025 Apr 25.
2
Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.
bioRxiv. 2024 Dec 16:2024.12.10.627800. doi: 10.1101/2024.12.10.627800.
3
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy.
Pharmacol Ther. 2025 Jan;265:108744. doi: 10.1016/j.pharmthera.2024.108744. Epub 2024 Nov 8.
4
Neurological glycogen storage diseases and emerging therapeutics.
Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14.
5
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy.
Mol Diagn Ther. 2024 Nov;28(6):703-719. doi: 10.1007/s40291-024-00733-x. Epub 2024 Aug 12.
6
Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model.
Respir Physiol Neurobiol. 2024 Aug;326:104282. doi: 10.1016/j.resp.2024.104282. Epub 2024 May 21.
7
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement.
Int J Mol Sci. 2023 Aug 26;24(17):13239. doi: 10.3390/ijms241713239.
8
Current avenues of gene therapy in Pompe disease.
Curr Opin Neurol. 2023 Oct 1;36(5):464-473. doi: 10.1097/WCO.0000000000001187. Epub 2023 Jul 19.
9
Optogenetic activation of the tongue in spontaneously breathing mice.
Respir Physiol Neurobiol. 2023 Mar;309:103998. doi: 10.1016/j.resp.2022.103998. Epub 2022 Nov 22.
10
Targeting drug or gene delivery to the phrenic motoneuron pool.
J Neurophysiol. 2023 Jan 1;129(1):144-158. doi: 10.1152/jn.00432.2022. Epub 2022 Nov 23.

本文引用的文献

1
The respiratory neuromuscular system in Pompe disease.
Respir Physiol Neurobiol. 2013 Nov 1;189(2):241-9. doi: 10.1016/j.resp.2013.06.007. Epub 2013 Jun 21.
5
Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement.
Neuromuscul Disord. 2013 Apr;23(4):319-23. doi: 10.1016/j.nmd.2012.12.003. Epub 2013 Jan 16.
7
Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9.
Hum Gene Ther Methods. 2012 Apr;23(2):148-56. doi: 10.1089/hgtb.2012.009.
8
Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.
Hum Gene Ther. 2012 Apr;23(4):382-9. doi: 10.1089/hum.2011.200. Epub 2012 Mar 28.
10
Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation.
Muscle Nerve. 2011 Dec;44(6):897-901. doi: 10.1002/mus.22202. Epub 2011 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验